newsfilter
← Latest News
PR Newswire·

CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders

SEATTLE, May 30, 2023 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for